{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:35:38Z","timestamp":1768469738914,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005045","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":51,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005045.pub2","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment for periodic paralysis"],"prefix":"10.1002","author":[{"given":"Valeria","family":"Sansone","sequence":"first","affiliation":[{"name":"University of Milan; Department of Neurology; Istituto Policlinico San Donato San Donato Milanese Milan Italy 20097"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Meola","sequence":"additional","affiliation":[{"name":"University of Milan; Department of Neurology; Istituto Policlinico San Donato San Donato Milanese Milan Italy 20097"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thera","family":"Links","sequence":"additional","affiliation":[{"name":"University of Groningen; Department of Endocrinology; PO Box 30.001 Groningen Netherlands 9700 RB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Panzeri","sequence":"additional","affiliation":[{"name":"Policlinico San Donato Milanese; Department of Neurology; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R","family":"Rose","sequence":"additional","affiliation":[{"name":"King's College Hospital; Department of Neurology; Academic Neuroscience Centre Denmark Hill London UK SE5 9RS"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD005045.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/cs0910583","article-title":"Normal insulin release during sustained hyperglycaemia in hypokalaemic periodicparalysis: role of the potassium channel opener pinacidil in impaired muscle strength","volume":"91","author":"Ligtenberg","year":"1996","journal-title":"Clinical Science (London)"},{"issue":"9","key":"10.1002\/14651858.CD005045.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/jnnp.51.9.1142","article-title":"Improvement of muscle strength in familial hypokalemic periodic paralysis with acetazolamide","volume":"51","author":"Links","year":"1988","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","article-title":"Randomized trials of dichlorphenamide in the periodic paralysis. Working Group on Periodic Paralyses","volume":"47(1)","author":"Tawil","year":"2000","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1212\/WNL.35.5.746","article-title":"Beta-Adrenergic treatment of hyperkalemic periodic paralysis","volume":"35 (5)","author":"Bendheim","year":"1985","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005045.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archneur.1973.00490250085013","article-title":"Myotonic periodic paralysis improved by negative sodium balance","volume":"29","author":"Brillman","year":"1973 July","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.54.1.87","article-title":"Familial hypokalemic periodic paralysis: prevention of paralytic attacks with lithium gluconate","volume":"54(1)","author":"Confavreux","year":"1991","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mus.880060303","article-title":"Treatment of 'permanent' muscle weakness in familial hypokalemic periodic paralysis","volume":"6","author":"Dalakas","year":"1983","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD005045.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08035259850157156","article-title":"Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline","volume":"87","author":"Djurhuus","year":"1998 Apr","journal-title":"Acta Paediatrica"},{"issue":"9","key":"10.1002\/14651858.CD005045.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archneur.1983.04050080039005","article-title":"Intravenous treatment of hypokalemic periodic paralysis","volume":"40","author":"Griggs","year":"1983","journal-title":"Archive of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD005045.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.65.2.248","article-title":"Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal sodium channel gene (SCN4A)","volume":"65","author":"Hanna","year":"1998","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD005045.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2169\/internalmedicine.41.743","article-title":"Acetazolamide-induced weakness in hypokalemic periodic paralysis","volume":"41","author":"Ikeda","year":"2002","journal-title":"Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005045.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0404.1977.tb01467.x","article-title":"Treatment of familial periodic hypokalemia with propranolol (Inderal)","volume":"56","author":"Johnsen","year":"1977","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0013|cit13","first-page":"525","article-title":"Trial of the prophylactic effect of diazoxide in the treatment of familial periodic hypokalemia","volume":"56(6)","author":"Johnsen","year":"1977 Dec","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.59.3.466","article-title":"Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome","volume":"59","author":"Junker","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005045.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-510X(94)90049-3","article-title":"Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects","volume":"122","author":"Links","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"issue":"11","key":"10.1002\/14651858.CD005045.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1564::AID-MUS38>3.0.CO;2-Y","article-title":"The calcium channel blocker verapamil in hypokalemic periodic paralysis","volume":"21","author":"Links","year":"1998","journal-title":"Muscle & Nerve"},{"issue":"5 suppl","key":"10.1002\/14651858.CD005045.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S953","DOI":"10.1007\/s100720070009","article-title":"Therapy in myotonic disorders and in muscle channelopathies","volume":"21","author":"Meola","year":"2000","journal-title":"Neurological Sciences"},{"issue":"10","key":"10.1002\/14651858.CD005045.pub2-BIB0018|cit18","first-page":"1449","article-title":"Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study","volume":"19","author":"Pope","year":"1984 Oct","journal-title":"Biological Psychiatry"},{"issue":"20","key":"10.1002\/14651858.CD005045.pub2-BIB0019|cit19","first-page":"1167","article-title":"Paralysis with hypokalemia by transfer, treated by acetazolamide","volume":"53","author":"Raphael","journal-title":"Le Semaine des Hopitaux"},{"issue":"6","key":"10.1002\/14651858.CD005045.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.31.6.725","article-title":"Acute effects of acetazolamide in hyperkalemic periodic paralysis","volume":"31","author":"Riggs","year":"1981","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0021|cit21","first-page":"149","article-title":"Therapy of paroxysmal hypokalemic paralysis: experience with diclofenamide","volume":"136","author":"Sander","year":"1988","journal-title":"Monatsscchrift Kinderheilkunde"},{"issue":"12","key":"10.1002\/14651858.CD005045.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.35.12.1805","article-title":"Beta-adrenergic treatment of hyperkalemic periodic paralysis","volume":"35","author":"Streib","year":"1985","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD005045.pub2-BIB0023|cit23","first-page":"171","article-title":"Myopathy in hypokalaemic periodic paralysis: reversal with acetazolamide","volume":"77","author":"Thompson","year":"1984","journal-title":"Irish Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD005045.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.31.11.1423","article-title":"Hypokalemic periodic paralysis exacerbated by acetazolamide","volume":"31","author":"Torres","year":"1981","journal-title":"Neurology"},{"issue":"2-3","key":"10.1002\/14651858.CD005045.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-510X(87)90093-1","article-title":"Hypokalemic periodic paralysis with unusual responses to acetazolamide and sympathomimetics","volume":"81","author":"Vern","year":"1987","journal-title":"Journal of the Neurological Sciences"},{"issue":"7953","key":"10.1002\/14651858.CD005045.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(76)91340-4","article-title":"Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol","volume":"1","author":"Wang","year":"1976","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD005045.pub2-BIB0027|cit27","first-page":"559","article-title":"Intermittent muscular weakness, extrasystoles, and multiple developmental abnormalities: a new syndrome?","volume":"60","author":"Andersen","year":"1971","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ana.1144","article-title":"Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis","volume":"50","author":"Bendahhou","year":"2001","journal-title":"Annals of Neurology"},{"issue":"51","key":"10.1002\/14651858.CD005045.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"51779","DOI":"10.1074\/jbc.M310278200","article-title":"Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome","volume":"278","author":"Bendahhou","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005045.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/17431380410032490","article-title":"Andersen-Tawil syndrome: a model of clinical variabiity, pleiotropy and genetic heterogeneity","volume":"36","author":"Donaldson","year":"2004","journal-title":"Annals of Medicine"},{"issue":"4983","key":"10.1002\/14651858.CD005045.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng0394-267","article-title":"Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families","volume":"6","author":"Fontaine","year":"1994","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1002\/14651858.CD005045.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-73-1-39","article-title":"Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness","volume":"73","author":"Griggs","year":"1970","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/2.9.1349","article-title":"A novel SCN4A mutation causing myotonia aggravated by cold and potassium","volume":"2","author":"Heine","year":"1993","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1002\/14651858.CD005045.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/3.8.1415","article-title":"A calcium channel mutation causing hypokalemic periodic paralysis","volume":"3","author":"Jurkat-Rott","year":"1994","journal-title":"Human Molecular Genetics"},{"issue":"17","key":"10.1002\/14651858.CD005045.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1073\/pnas.97.17.9549","article-title":"Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current","volume":"97","author":"Jurkat-Rott","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 6","key":"10.1002\/14651858.CD005045.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/brain\/113.6.1873","article-title":"Permanent muscle weakness in familial hypokalemic periodic paralysis","volume":"113","author":"Links","year":"1990","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD005045.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1092-148","article-title":"Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel","volume":"2","author":"McClatchey","year":"1992","journal-title":"Nature Genetics"},{"issue":"8","key":"10.1002\/14651858.CD005045.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mus.880090805","article-title":"The exercise test in periodic paralysis","volume":"9","author":"McManis","year":"1986","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD005045.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1002\/14651858.CD005045.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(91)90374-8","article-title":"Identification of a mutation in the gene causing hyperkalemic periodic paralysis","volume":"67","author":"Ptacek","year":"1991","journal-title":"Cell"},{"issue":"2","key":"10.1002\/14651858.CD005045.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.42.2.431","article-title":"Linkage of atypical myotonia congenita to a sodium channel locus","volume":"42","author":"Ptacek","year":"1992","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD005045.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.44.8.1500","article-title":"Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis","volume":"44","author":"Ptacek","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD005045.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0092-8674(94)90135-X","article-title":"Dihydropyridine receptor mutations cause hypokalemic periodic paralysis","volume":"77","author":"Ptacek","year":"1994","journal-title":"Cell"},{"issue":"11","key":"10.1002\/14651858.CD005045.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJM196803142781102","article-title":"Acetazolamide prophylaxis in hypokalemic periodic paralysis","volume":"278","author":"Resnick","year":"1968","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD005045.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.33.12.1615","article-title":"Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis","volume":"33","author":"Ricker","year":"1983","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005045.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/354387a0","article-title":"A Met-to-Val mutation in the skeletal muscle Na+ channel alfa-subunit in hyperkalaemic periodic paralysis","volume":"354","author":"Rojas","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410420306","article-title":"Andersen's syndrome: a distinct periodic paralysis","volume":"42","author":"Sansone","year":"1997","journal-title":"Annals of Neurology"},{"issue":"Pt 6","key":"10.1002\/14651858.CD005045.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/brain\/124.6.1091","article-title":"Hypokalemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A","volume":"124","author":"Sternberg","year":"2001","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005045.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005045.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:43:59Z","timestamp":1628545439000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005045.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005045.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}